The LeMont Restaurant will be painted with the excitement of a Las Vegas style casino for The Leukemia & Lymphoma Society's Vegas on the Mon at LeMont event. On Thursday, November 1, 2012, over 400 guests will enjoy the evening of chips, cards and delicious cuisine. Traditional games like roulette, blackjack and craps will have guests gambling with their Vegas money. Highlighting the evening is the Pittsburgh Hold 'em tournament where major sponsors will be able to select one player to press their luck at winning a research grant named after their company. Chinese and Silent Auctions will also be featured during the evening, allowing the guests the opportunity to bid on travel packages, Steelers items, artwork, event tickets and jewelry. Vegas on the Mon at LeMont will be a wonderful night of great food and entertainment while supporting a mission to cure blood cancers. For more information, or for ticket or sponsorship opportunities, please call The Society office at (412) 395-2873.
Location of event:
The LeMont Restaurant
1114 Grandview Avenue
Dr. Stanley Marks
Director of Clinical Services, UPMC Cancer Center
Trib Total Media
Mark Mason, Oxford Development Company
Jack Kessler, Buchanon Ingersoll & Rooney, P.C.
Levels of Sponsorships:
We are still in the process of securing sponsors. If you, your company or organization is interested in supporting this very worthwhile cause, please contact Jeanne Caliguiri or Richele Ward at (412) 395-2873 or click the links below to view the sponsorship information:
Director of Development
Senior Campaign Director
Ticket Prices: $175
To Purchase a Ticket, Call The Leukemia & Lymphoma Society: (412) 395-2873.
Estimated Attendance: 400 guests
Estimated Dollar Amount Raised: Approximately $200,000
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The Society's mission: cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $750 million for research specifically targeting blood cancers.
Federal Tax ID: